VITRASE Drug Patent Profile
✉ Email this page to a colleague
When do Vitrase patents expire, and when can generic versions of Vitrase launch?
Vitrase is a drug marketed by Bausch And Lomb and is included in one NDA.
The generic ingredient in VITRASE is ganciclovir. There are twenty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ganciclovir profile page.
Summary for VITRASE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VITRASE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for VITRASE |
DailyMed Link: | VITRASE at DailyMed |
Recent Clinical Trials for VITRASE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Bausch & Lomb Incorporated | Phase 2 |
Bausch & Lomb Incorporated | Phase 3 |
Bausch & Lomb Incorporated | Phase 4 |
US Patents and Regulatory Information for VITRASE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch And Lomb | VITRASERT | ganciclovir | IMPLANT;IMPLANTATION | 020569-001 | Mar 4, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |